OA09387A - "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues". - Google Patents

"Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".

Info

Publication number
OA09387A
OA09387A OA60055A OA60055A OA09387A OA 09387 A OA09387 A OA 09387A OA 60055 A OA60055 A OA 60055A OA 60055 A OA60055 A OA 60055A OA 09387 A OA09387 A OA 09387A
Authority
OA
OAPI
Prior art keywords
compositions
sustained
preparation
release
release compositions
Prior art date
Application number
OA60055A
Other languages
English (en)
French (fr)
Inventor
Ruiz Jean-Marc
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of OA09387A publication Critical patent/OA09387A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA60055A 1990-08-01 1991-08-01 "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues". OA09387A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
OA09387A true OA09387A (fr) 1992-09-15

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60055A OA09387A (fr) 1990-08-01 1991-08-01 "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".

Country Status (30)

Country Link
US (1) US5213812A (enExample)
JP (1) JP2818704B2 (enExample)
KR (1) KR920003962A (enExample)
AT (1) AT396425B (enExample)
AU (2) AU649696B2 (enExample)
BE (1) BE1004772A3 (enExample)
CA (1) CA2048270C (enExample)
CH (1) CH682715A5 (enExample)
DE (1) DE4125542A1 (enExample)
DK (1) DK175756B1 (enExample)
ES (1) ES2046083B1 (enExample)
FI (1) FI104149B (enExample)
FR (1) FR2665360B1 (enExample)
GB (1) GB9016885D0 (enExample)
GR (1) GR1001512B (enExample)
HK (1) HK33294A (enExample)
IE (1) IE65124B1 (enExample)
IN (1) IN178446B (enExample)
IT (1) IT1251788B (enExample)
LU (1) LU87982A1 (enExample)
MA (1) MA22245A1 (enExample)
MY (1) MY107500A (enExample)
NL (1) NL194637C (enExample)
NO (1) NO300158B1 (enExample)
NZ (1) NZ238981A (enExample)
OA (1) OA09387A (enExample)
PT (1) PT98497B (enExample)
SE (1) SE505734C2 (enExample)
TN (1) TNSN91067A1 (enExample)
ZA (1) ZA915565B (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
ES2188652T3 (es) * 1994-02-28 2003-07-01 Nanopharm Ag Sistema de direccionado de farmacos, metodos de fabricacion y uso del mismo.
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
WO1998015263A2 (en) * 1996-10-09 1998-04-16 Takeda Chemical Industries, Ltd. A method for producing a microparticle
AR012448A1 (es) * 1997-04-18 2000-10-18 Ipsen Pharma Biotech Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
EP1079967A4 (en) 1998-04-13 2003-07-23 Luminex Corp LIQUID MARKING USING FLUORESCENT MICROPARTICLES
OA11728A (en) * 1998-12-16 2005-02-01 Aventis Pharma Inc Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same.
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
ES2326209T3 (es) 2000-10-27 2009-10-05 Baxter Healthcare S.A. Produccion de microesferas.
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
PT1418890E (pt) * 2001-08-16 2008-06-09 Baxter Int Formulações de micropartículas à base de propulsor
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
AU2004280158B2 (en) * 2003-07-18 2011-02-17 Baxter International, Inc. Methods for fabrication, uses and compositions of small spherical particles prepared by controlled phase separation
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
CA2532874A1 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US8333995B2 (en) * 2004-05-12 2012-12-18 Baxter International, Inc. Protein microspheres having injectable properties at high concentrations
JP2007537284A (ja) 2004-05-12 2007-12-20 バクスター インターナショナル インコーポレイテッド 核酸マイクロスフェア、その生成および送達
EP1758558B1 (en) * 2004-05-12 2013-10-16 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
EP1773264A1 (en) * 2004-07-13 2007-04-18 Altairnano, Inc Ceramic structures for controlled release of drugs
CA2573341A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
WO2006050345A1 (en) * 2004-10-29 2006-05-11 Adhesives Research, Inc. Microscopic tagging system for security identification
WO2006116546A1 (en) * 2005-04-27 2006-11-02 Baxter International Inc. Surface-modified microparticles and methods of forming and using the same
EP1928814A2 (en) * 2005-08-23 2008-06-11 Altairnano, Inc HIGHLY PHOTOCATALYTIC PHOSPHORUS-DOPED ANATASE-TiO2 COMPOSITION AND RELATED MANUFACTURING METHODS
US20080038482A1 (en) * 2006-03-02 2008-02-14 Fred Ratel Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
WO2007103820A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured indium-doped iron oxide
US20080008843A1 (en) * 2006-03-02 2008-01-10 Fred Ratel Method for Production of Metal Oxide Coatings
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
EP2056883B1 (en) 2006-08-04 2021-09-22 Baxter International Inc. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
CA2663589A1 (en) * 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
US9017697B2 (en) 2006-10-12 2015-04-28 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
WO2008128000A1 (en) * 2007-04-12 2008-10-23 Altairnano, Inc. Teflon replacements and related production methods
CN101686939B (zh) * 2007-04-17 2013-03-27 巴克斯特国际公司 用于肺部投送的核酸微粒
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
ES2554168T3 (es) 2008-04-18 2015-12-16 Baxter International Inc. Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100078848A1 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
US20100291384A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CN102481374A (zh) * 2009-05-27 2012-05-30 西莱克塔生物科技公司 具有免疫调节剂的pH敏感释放的靶向合成纳米载体
US20110076771A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
JP6324068B2 (ja) 2010-05-26 2018-05-23 セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． 合成ナノキャリア混合ワクチン
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞（ctl）免疫应答的合成纳米载体
EP3149049B1 (en) 2014-05-27 2022-10-26 The University Of Queensland Il-22 for use in treating metabolic disorders
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (enExample) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
US5213812A (en) 1993-05-25
KR920003962A (ko) 1992-03-27
AU8146691A (en) 1992-02-06
DK175756B1 (da) 2005-02-14
FR2665360B1 (fr) 1995-02-10
IE65124B1 (en) 1995-10-04
DK141891A (da) 1992-02-02
LU87982A1 (fr) 1992-04-15
GR910100330A (en) 1992-08-31
FR2665360A1 (fr) 1992-02-07
FI104149B1 (fi) 1999-11-30
ITMI911953A0 (it) 1991-07-15
FI913646A0 (fi) 1991-07-31
ES2046083A1 (es) 1994-01-16
BE1004772A3 (fr) 1993-01-26
JPH05178740A (ja) 1993-07-20
HK33294A (en) 1994-04-22
ITMI911953A1 (it) 1993-01-15
GR1001512B (el) 1994-02-28
FI104149B (fi) 1999-11-30
AU666808B2 (en) 1996-02-22
SE9102249L (sv) 1992-02-02
JP2818704B2 (ja) 1998-10-30
IE912700A1 (en) 1992-02-12
IN178446B (enExample) 1997-05-03
GB9016885D0 (en) 1990-09-12
CH682715A5 (fr) 1993-11-15
CA2048270A1 (en) 1992-02-02
TNSN91067A1 (fr) 1992-10-25
ZA915565B (en) 1992-04-29
MA22245A1 (fr) 1992-04-01
NO912986D0 (no) 1991-07-31
PT98497B (pt) 1997-10-31
NL9101306A (nl) 1992-03-02
DE4125542A1 (de) 1992-02-06
CA2048270C (en) 1997-02-25
IT1251788B (it) 1995-05-26
DK141891D0 (da) 1991-07-31
AT396425B (de) 1993-09-27
ES2046083B1 (es) 1994-08-01
MY107500A (en) 1995-12-30
NO300158B1 (no) 1997-04-21
SE505734C2 (sv) 1997-10-06
SE9102249D0 (sv) 1991-07-26
PT98497A (pt) 1992-06-30
AU649696B2 (en) 1994-06-02
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
NL194637C (nl) 2002-10-04
ATA152591A (de) 1993-01-15
FI913646L (fi) 1992-02-02
AU5939394A (en) 1994-06-02
NZ238981A (en) 1992-11-25

Similar Documents

Publication Publication Date Title
OA09387A (fr) "Procédé de préparation de compositions à libération prolongée et compositions ainsi obtenues".
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FR2720070B1 (fr) Procédé de préparation d'alkylpolysiloxanes pontés et alkylpolysiloxanes pontés.
EP0657438A3 (en) Process for the preparation of alkylsulfinylbenzamides and 1,2-benzisothiazol-3-ones.
EP0685491A3 (en) Process for producing albumin preparation.
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
FR2594839B1 (fr) Procede de fractionnement d'asphaltes solides
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
FR2712492B1 (fr) Compositions cosmétiques à base d'eaux thermales et leur procédé de préparation.
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
FI910159A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 9a-hydroksi-3-okso- 4,24(25)-stigmastadieeni-26-happojohdannaisten valmistamiseksi
FR2716203B1 (fr) Procédé de préparation de violanthrones ou d'isoviolanthrones chlorées.
FI880282L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi
FR2653860B1 (fr) Procede de fabrication d'un conduit de fumee et conduit de fumee ainsi obtenu.
ITMI910504A0 (it) Disponibilita' di micro-elementi per piante
FR2694933B1 (fr) Procédé de préparation d'isocyanates d'acyle.
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
FR2714385B1 (fr) Copolymère d'acide phosphonique-carboxylique et procédé de préparation de ce copolymère.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
FR2712594B1 (fr) Procédé de préparation de l'oenotheine B à partir d'Epilobium Parviflorum.
FR2630741B1 (fr) Procede de preparation d'acryloyloxyethoxymethyl-melamines